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Abstract: Physicochemical properties of chemicals affect their exposure, toxicokinetics/fate 
and hazard, and for nanomaterials, the variation of these properties results in a wide variety of 
materials with potentially different risks. To limit the amount of testing for risk assessment, 
the information gathering process for nanomaterials needs to be efficient. At the same time, 
sufficient information to assess the safety of human health and the environment should be 
available for each nanomaterial. Grouping and read-across approaches can be utilised to 
meet these goals. This article presents different possible applications of grouping and  
read-across for nanomaterials within the broader perspective of the MARINA Risk 
Assessment Strategy (RAS), as developed in the EU FP7 project MARINA. Firstly, 
nanomaterials can be grouped based on limited variation in physicochemical properties to 
subsequently design an efficient testing strategy that covers the entire group. Secondly, 
knowledge about exposure, toxicokinetics/fate or hazard, for example via properties such 
as dissolution rate, aspect ratio, chemical (non-)activity, can be used to organise similar 
materials in generic groups to frame issues that need further attention, or potentially to 
read-across. Thirdly, when data related to specific endpoints is required, read-across can be 
considered, using data from a source material for the target nanomaterial. Read-across 
could be based on a scientifically sound justification that exposure, distribution to the 
target (fate/toxicokinetics) and hazard of the target material are similar to, or less than, the 
source material. These grouping and read-across approaches pave the way for better use of 
available information on nanomaterials and are flexible enough to allow future adaptations 
related to scientific developments.  
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1. Introduction 
Nanomaterials (NMs) have many physicochemical properties that can affect their exposure, 
toxicokinetics/fate and hazard [1–6]. NMs that have slightly different physicochemical properties, for 
example a small variation in the surface characteristics or in the size distribution, may potentially have 
significantly different risk profiles. At present, the knowledge on relationships between such variation 
in physicochemical properties and variation in effects of NMs is limited [7], and systematic gathering 
of information across NMs is therefore encouraged. At the same time, there is a high, and challenging, 
need for efficient approaches aimed to information gathering for risk assessment, which should ensure 
that sufficient information is available to assess the safety of NMs while minimising the need for 
animal testing. This urgency is felt by industry and regulatory authorities alike, as the costs to warrant 
safety by extensive testing of each slightly different NM, and to assess each material, could be 
exorbitant and could hamper innovation in the field. Furthermore, extensive in vivo testing would 
challenge the international ethically based intention to reduce animal testing.  
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Approaches supporting the risk assessment of NMs should be applicable at present, as well as 
sufficiently flexible to allow incorporation of future scientific developments relating to knowledge on 
NM behaviour and material innovation. Such approaches include risk assessment strategies, identification 
of generic groups to guide efficient testing of NMs, and read-across between nano and non-nanomaterials.  
A Risk Assessment Strategy (RAS) that addresses specific challenges for NMs, including how to 
perform risk assessment for the significant number of NMs currently in development or already marketed, 
as well as dealing with the changes in physicochemical properties of NMs during their life cycle, is 
developed in the context of the EU-funded FP7 project MARINA (http://www.marina-fp7.eu/). The 
MARINA RAS is designed to use the scientific insights on NMs and provide a generic framework, 
allowing it to be considered and embraced by other projects and organisations. The outline of the 
MARINA RAS is described by Bos et al. [8]. One of the challenges in developing efficient risk 
assessment approaches for NMs is to make best use of the-still scarce-available information and data 
on physicochemical properties, exposure, toxicokinetics, fate, and hazard. Grouping and read-across 
approaches for NMs can help to streamline this best use of information.  
2. Aim 
The aim of the present manuscript is to describe the integration of grouping and read-across 
approaches in the NM-tailored MARINA RAS. This should serve the overall purpose of efficient 
information gathering for risk assessment of NMs in a way that ensures that safety can be assessed. 
3. Terminology 
For clarity, the terms group and read-across are defined for the purpose of this paper.  
A group represents a number of NMs which share a commonality relevant for risk, which can be 
one or more common property(ies) in a physical, chemical, exposure, (eco)toxicological, 
toxicokinetics or fate sense. A NM can belong to more than one group.  
Read-across refers to predicting hazard information on one or more endpoints relevant for risk 
assessment of one NM or more NMs (target material(s)) by using data from another NM or more NMs 
(source material(s)). The source materials can also be non-nano.  
In a regulatory context, the OECD (Organisation for Economic Co-operation and Development) [9] 
has issued general guidance on grouping and read-across via the document “Guidance on Grouping of 
Chemicals, Second Edition”, available at http://www.oecd.org/chemicalsafety/risk-assessment/ 
groupingofchemicalschemicalcategoriesandread-across.htm. Furthermore, in the EU, the European 
Chemicals Agency (ECHA) has defined read-across for chemicals in general [10] as a technique for 
predicting endpoint information for one substance (target substance) by using data for the same endpoint 
from another substance or other substances (source substances). As this definition was developed before 
NMs were considered in regulations, read-across refers to predicting information from one substance to 
another. In the present paper, the term read-across also refers to data sharing between NMs and/or  
non-NMs of the same substance, for example from one specific (nano) form of titanium dioxide to another 
specific (nano) form of titanium dioxide. 
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4. Key Elements  
In the present paper, the application of approaches for grouping and read-across are explored for 
NMs. To that end, five key elements that need to be taken into account are discussed.  
A first key element is that grouping and read-across for NMs should be useful approaches in a 
regulatory framework or strategy for risk assessment. The present concepts for grouping and  
read-across for NMs are put into the broader scope of the MARINA RAS [8]. Furthermore, the RAS 
should allow application of grouping and read-across for NMs now and be sufficiently flexible to 
accommodate future increases in knowledge and material development.  
A second key element is that proposals for grouping and read-across of NMs should be based on a 
solid scientific justification. This is required for chemicals in general under the EU REACH legislation 
(Regulation (EC) No 1907/2006), recommended in the OECD guidance on general principles for 
grouping [9], and also indicated by the ECHA Group Assessing Already Registered  
Nanomaterials (GAARN) [11].  
A third element is that the NMs considered should be unequivocally identified and characterized. 
This information is used (1) to assess what information on the specific NM is already available, and (2) 
for risk assessment, including grouping and read-across options. Without this information to 
characterize the NMs, these processes cannot be initiated. Several initiatives propose similar sets of 
physicochemical properties to characterize NMs [1,11–14]. Figure 1 presents a set of physicochemical 
properties that can affect exposure, toxicokinetics, fate and/or (eco)toxicological behaviour, and is 
based on Sellers et al. [1]. As is the case for substances in general, impurities in NMs may also 
contribute to or determine the toxicity and should therefore be identified. The properties are  
sub-divided into four classes that were proposed by Stone et al. [5]: “What they are”: Chemical 
identity, “What they are”: Physical identity, “Where they go”: Fundamental behaviour, and “What they 
do”: Reactivity. Hence, as each specific NM can have a different risk profile, the current knowledge 
indicates that information on these key properties needs to be considered. The properties related to 
chemical and physical identity can be used to support a first comparison of the specific NM to other NMs. 
A fourth element is that, as described by Oomen et al. [4] and Arts et al. [2,3], a sequence of events 
takes place between NM production and the potential occurrence of a toxic effect, as illustrated in 
Figure 2. Physicochemical properties affect the whole life cycle of the material including the biological 
pathway in potentially different ways. It is thus key that this is taken into account for grouping and 
read-across among NMs. Here, this is addressed by the option to consider the influence of changes in 
physicochemical properties on exposure, toxicokinetics and hazard, separately, followed by integration 
for assessment purposes. 
A final element relates to the mechanistic toxicological pathways. It has been discussed by several 
authors (e.g., Nel et al. [15], Donaldson and Poland [16] and Gebel et al. [17]) that there seem to be no 
new modes of action for NMs compared to the modes of action already known for non-nano materials. 
Moreover, in contrast to non-nano materials, the number of toxicological mechanistic pathways for 
NMs seems to be limited to a handful [2,15,17], and may be related to the limited potential of the 
(predominantly investigated metal, metal oxide and carbon based) NMs for chemically-based  
receptor-binding. This element may streamline and simplify grouping and read-across for a target NM, 
and application of these nano-specific insights in the MARINA RAS should be possible. 




Figure 1. Key properties that characterize a NM (adapted from Seller et al. [1]), arranged 
under headings from ITS-NANO [5], and coloured in accordance with Figure 2. These 
properties can affect exposure, toxicokinetics, fate and/or (eco) toxicological behaviour 
and thus the risk posed by NMs, and constitute the basic information needed  
(based on current knowledge) to implement the assessment in Figures 3–5. The 
information on chemical and physical identity (“What they are”) can be used for a first 
comparison of a certain NM to other NMs. Note that (i) some properties may not be 
relevant for all NMs, for example dustiness only applies to powders; (ii) some properties 
(for example dispersibility, dustiness) are system-dependent properties, and (iii) the key 
physicochemical properties are based on the present knowledge derived mostly from 
studying NMs that are metals, metal oxides or carbon based. Legend for the superscript 
numbers providing additional information on the properties: 1. Chemical composition 
comprises crystal structure; 2. Surface characteristics, which includes coating chemistry, 
functionalization (e.g., capping agents), surface charge (e.g., zeta potential); 3. Surface 
area, which includes porosity; 4. Solubility includes water equilibrium solubility and rate 
of dissolution in relevant media; 5. Hydrophobicity for NMs is dependent on  
e.g., van der Waals energy, Hamaker constant, zeta potential. Analytical determination of 
the hydrophobicity of NMs is still under development, e.g., sessile drop contact angle, dye 
adsorption; 6. Dispersibility refers to the relative number or mass of particles in a 
suspending medium, and relates to stability [1], aggregation and agglomeration in relevant 
media, and is dependent on e.g., van der Waals energy, Hamaker constant, zeta potential;  



















“What they are”: 
Chemical identity





“What they do”: 
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Figure 2. A sequence of events in the life cycle and the biological pathways that can 
influence the apical effect (adapted from Arts et al. [2], Arts et al. [3], Oomen et al. [4]). 
Material physicochemical properties (blue) affect exposure (orange), toxicokinetics 
(yellow, green) and hazards (pink, red) in potentially different ways, and thereby influence the 
apical effect. This should be taken into consideration in grouping and read-across approaches 
5. Existing Concepts for Grouping and Read-Across of NMs 
The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Task Force on 
the Grouping of Nanomaterials recently reviewed the available concepts for the grouping of NMs for 
human health risk assessment [3], which is referred to for a more detailed overview of existing 
concepts for grouping. Briefly, grouping concepts for nanomaterials have also been developed by the 
British Standards Institute (https://nanohub.org/groups/gng/guidelines), the German Federal Institute 
for Occupational Safety and Health [18], Kuempel et al. from US NIOSH [19], and Gebel et al. [17]. 
As discussed by Gebel et al. [17] and Arts et al. [3] these concepts are generally consistent with each 
other. These groups are referred to by Gebel et al. [17] as a group with “chemically mediated toxicity”, 
“toxicity caused by certain fibrous NMs”, and “toxicity through granular biodurable nanoparticles”. In 
later publications, these groups were referred to as “active NMs”, “biopersistent high aspect ratio 
(HAR) NMs” and “passive NMs” respectively, and supplemented by a group with “soluble NMs” [2]. 
Godwin et al. [20] also summarized approaches to grouping and ranking NMs, differentiating by 
categorization according to “physicochemical properties”, “exposure and use scenarios” and “linking 
selected physicochemical properties to specific biological outcomes”. 
It should be noted that these concepts generally describe broad groups of NMs and focus mainly on 
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according to these proposals will not enable risk assessment-based decisions, as information may be 
too limited to draw clear conclusions and because these groups may still be too heterogeneous with 
regard to the various physicochemical properties. Information from similar materials as in these 
grouping proposals can aid in highlighting those issues that need specific attention in risk assessment. 
In some cases, it may be possible to identify a group of NMs for which read-across early in the risk 
assessment process is feasible. For example, read-across to the solute of quickly dissolving NMs may 
be possible. In other cases, there is a need to identify under which circumstances data from certain 
materials in the group can be used to fill in data gaps of a new material endpoint-by-endpoint.  
6. Grouping and Read-Across among NMs within the MARINA Risk Assessment Strategy 
In the present paper, the integration of approaches for grouping and read-across among NMs into 
the MARINA RAS is discussed. This strategy is composed of two phases: “Phase 1: Problem 
Framing” and “Phase 2: Risk Assessment” (see Figures 3 and 4). The aim of Phase 1 is to obtain a 
basic view of the potential risk of the NM by identifying Relevant Exposure Scenarios (RESs) 
throughout an NM’s life cycle and verifying whether exposure in these scenarios may potentially lead 
to adverse health and/or environmental effects. “Relevant” in this context means important from the 
viewpoint of exposure, fate, toxicokinetics and/or hazard, and thus demanding further evaluation in 
Phase 2. The Problem Framing Phase should (i) define the scope of Phase 2 by evaluating all available 
information, including a set of basic requirements, and defining information and/or testing 
requirements to be addressed in Phase 2, and (ii) provide guidance for the strategy to collect this 
information. More details on the MARINA RAS can be found in Bos et al. [8]. 
According to the MARINA RAS, information on key physicochemical properties of a NM should 
be available to support Phase 1. Furthermore, in Phase 1 basic exposure information, at least based on 
the intended use (which includes physical form and anticipated exposure route(s)), and basic 
toxicokinetic and hazard information need to be available. Information from similar materials and 
applications may be used. This includes exposure information related to the physical form  
(e.g., powder, suspension) in combination with similar applications and/or processes. This kind of 
information is for example gathered in the MARINA exposure scenario library for NMs [21], or 
related to qualifiers on use, release and route of exposure as indicated in Arts et al. [2]. By combining 
physicochemical, exposure, kinetic and hazard information, RESs are identified for further 
consideration in Phase 2 of the strategy. In some cases, these elements of basic information may 
indicate already in Phase 1 that risks (for some uses) are expected to be high, which should be 
considered in further development and/or application of the NM under consideration. By identifying a 
likely risk, a number of measures can be considered, including avoiding specific exposure routes via 
modification (or withdrawal) of the material/product, risk management measures such as application of 
safer designs or personal protective equipment. The time and costs needed to obtain all information 
required for risk assessment should be evaluated taking into account also potential benefits and profits 
and the likelihood of regulatory acceptance after further testing. For example, the information, of 
physicochemical nature, that a material is an HAR material, can be an alert for a possible specific 
human health hazard (asbestos-like effects), and the potential application of this material should be 
carefully considered based on this information.  





Figure 3. Schematic overview of the MARINA Risk Assessment Strategy, consisting of an 
overarching Phase 1: Problem Framing (orange), and the iterative Phase 2: Risk 
Assessment (green) with a cyclic evaluation process. The information gathering is 
organised in three pillars (Exposure, Fate/Toxicokinetics and Hazard). The integration of 
the gathered information to derive a conclusion on risk is represented by a separate pillar 
i.e., Risk characterization. Each pillar comprises tools both for Phases 1 and 2  
(from Bos et al. [8]). RES: Relevant Exposure Scenario. RMO: Risk Management Options. 
Several different possibilities for application of grouping and read-across in the two Phases of the 
MARINA RAS are illustrated in Figure 4; the numbers of the following sections correspond to the 
numbers in Figure 4. 




Figure 4. Possible applications of grouping and read-across of NMs (yellow boxes) in 
Phase 1 (orange box) and 2 (green box) of the MARINA Risk Assessment Strategy (RAS). 
These boxes are explained in more detail in the text in order of their numbering. The white 
boxes with green dotted outline represent input of data. HAR: High Aspect Ratio;  
RES: Relevant Exposure Scenario. 
6.1. Ad One: Grouping to Design A Testing Strategy Whose Results Cover An Entire Group of NMs 
This application of grouping is a pragmatic approach where it is not an individual NM that “enters” 
the MARINA RAS, but a group of NMs. In this case, data for risk assessment purposes can be 
gathered in an efficient way by testing a few selected NMs in the group and interpolate test results to 
cover the entire group. To that end, a group of NMs needs to be identified before testing is performed, 
i.e., prior to or at the start of Phase 1 in the MARINA RAS. A proposal for grouping is mainly based 
on limited variation in physicochemical properties of NMs and their intended use (this input 
information is indicated in upper white box with green dotted outline in Figure 4). The physicochemical 
properties that should be available from the beginning for each NM are listed in the chemical and physical 
identity columns in Figure 1, and are used to determine if and what information on the investigated NMs is 
already available, and to compare the NMs to conclude whether they can form a group for risk assessment 
purposes. In addition, intended use(s) should be considered in the group proposal as this is associated with 
the physical form, relevant exposure routes and exposure potential. Selected NMs of the proposed group 
can subsequently be tested according to the MARINA RAS so that the outcome of the testing would cover 
the entire group by interpolation on an endpoint basis (i.e., in Phase 2 of the MARINA RAS). To that end, 
at least the NMs that define the borders of variation in physicochemical property/ies are investigated, 
as well as some NMs in between to support a certain trend between variable properties and an effect. 
Depending on the number of variable physicochemical properties within the group, a multi-dimensional 
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space of several physicochemical properties will have to be described. The applicability of the test 
results from selected NMs to the entire group may be further substantiated by argumentation on the 
likelihood of trends between the variable physicochemical properties, toxicokinetics and hazard 
relevant for a certain endpoint based on general trends described in available scientific knowledge. The 
argumentation can also be strengthened with additional data, i.e., physicochemical, in vitro, or in vivo 
data. For example, in vitro hazard data on a larger number of NMs from the group that confirm the 
relationship between the variable physicochemical property and an effect can be generated and used to 
substantiate the applicability of in vivo data on a few NMs for the entire group. In this way information 
for the non-tested NMs in the group can be obtained by interpolation of the test results for the NMs 
that define the borders of the variation in physicochemical properties and subsequent analysis of the 
results. Interpolation is proposed here rather than extrapolation due to the current limited 
understanding in behaviour and effects of NMs related to NM variation in physicochemical properties. 
Finding groups of NMs for which data can be generated to cover the entire group may be 
challenging. In some cases, the production process may provide a starting point for formation of such a 
group. If the same production process is used with slightly different conditions  
(for example temperature and/or pressure), the size or size distribution may be different depending on 
these conditions, but other properties such as chemical composition, particle shape, surface properties, 
etcetera can be the same. These NMs can be grouped to subsequently design a testing strategy for one 
or more endpoints, for example according to the MARINA RAS, and whose results can cover  
the entire group. 
Furthermore, properties that vary within the group may, to some extent, correlate. For example, size 
and specific surface area correlate to a certain extent, though the lowest average primary particle size 
does not necessarily correspond to the highest specific surface area (as for the latter the entire size 
distribution, shape and porosity is considered). Such correlations between physicochemical properties 
within a group can decrease the number of NMs that define the borders of the variation in 
physicochemical properties and thus reduce the number of tests that are required to cover the entire 
group. At present, groups of NMs with variation in properties such as chemical composition, type of 
surface coating and functionalization, general shape (sphere, tube, sheet, etc.) are generally not suitable 
for the type of approach described above, as the NMs cannot be arranged on a continuous scale so that 
the NMs that define the borders of variation in physicochemical properties cannot be identified. For 
variations in size, thickness or % of a specific coating surface charge et cetera the above approach is 
considered feasible. 
After information gathering and testing in Phases 1 and 2 of the MARINA RAS, it should be 
considered if the proposed grouping is indeed applicable and justifiable. If the test results of the NMs, 
which are on the borders of variation in physicochemical properties, are very different, subgrouping 
may be an option. The end of Phase 1 is a first assessment opportunity on whether the proposed 
grouping is expected to be applicable, justifiable and useful for the intended application, and if further 
information gathering in Phase 2 is worthwhile.  
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6.2. Ads Two, Three and Four: Grouping That Steers The Risk Assessment Process 
The groupings to indicate possibilities for read-across early in the risk assessment (ad 2), to 
highlight information needs based on hazard (ad 3), and to highlight information needs based on 
exposure (ad 4) can all be used to steer the risk assessment process based on existing knowledge on 
similar materials. The groups according to Arts et al. [2], which are similar to several other proposed 
groupings for NMs, can be used for steering the information gathering process in relation to certain 
endpoints/issues that need special attention based on experience with similar materials, e.g., experience 
with other quickly dissolving NMs, other NMs with HAR, other passive NMs or other active NMs. 
The group “soluble NMs” that is defined by Arts et al. [2] by a water solubility above 100 mg/l, 
solubility in biological media or a pulmonary half-life of less than 40 days, is adapted in this paper to a 
group of “quickly dissolving NMs”. For NMs in this group, it is possible to argue early in the process 
for read-across to data on the solute or bulk form, if this information is available. In the present 
publication, no definition of “quickly” will be proposed, though, clearly, the term needs further 
specification. For environment, “quickly” relates to the time frame for dissolution of the NM in 
environmentally relevant media for fate and ecotoxicity. For human health, “quickly” relates to 
dissolution in physiologically relevant media in relation to physiologically relevant time frames. More 
specifically, for the oral exposure route, the conditions relevant for transit through and uptake by the 
gastrointestinal tract should be considered. This concept is applied in an EFSA guidance that allows 
for reduced information requirements when an NM completely dissolves or degrades under conditions 
and in time frames relevant for the human gastrointestinal tract [22]. For inhalation exposure, the 
relevant time frame is determined by the time needed for dissolution in lung lining fluid combined 
with the time frames for removing particulate matter (i.e., the time required by the mucociliary 
escalator to remove particulate matter from the respiratory tract, and cellular uptake of NMs from the 
lung lining fluid). For dermal exposure, the conditions on the skin, residence time on the skin, and 
translocation through the skin needs to be considered. Issues, which need to be considered for NMs 
that quickly dissolve, are local and systemic acute effects related to e.g., release of ions, as also 
indicated by Kuempel et al. [19]. 
The group of “soluble NMs” is presently adapted to “quickly dissolving NMs”, as differentiation 
should be made between complete dissolution before translocation across the portal of entry  
(i.e., lung epithelium, gastrointestinal lining, skin), and partial dissolution or degradation into smaller 
particles. In the latter case, information of the solute cannot be automatically used, as uptake of 
particles can result in different distribution to organs and cells thus in different toxicity than for the 
solute [23]. It should be noted that information on the solubility and dissolution rate, especially in 
physiologically and environmentally relevant media, also provide insight into the likely biopersistence, 
potential for accumulation and long-term effects of a NM [24].  
The identity of the solute is not always straightforward, as an NM may dissolve into different 
solutes. Metals, metal oxides and salts will usually dissolve into ions. The solute of other materials 
such as carbon based materials, (non-metal) pigments and polymers will often be less clear and the 
solute may, for example, depend on the degree of hydroxylation. It is therefore necessary to determine 
the solute in relevant media and conditions to be clear if and to which solute read-across can be performed.  
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Other groups indicated by Arts et al. [2] are “NMs with a High Aspect Ratio (HAR)”, “passive 
NMs”, and “active NMs”. As indicated, these groupings focus on human health and can help to 
highlight the information needs for a specific NM or a group of NMs. For example, NMs that fall into 
the group with an HAR would most likely induce toxic effects due to their morphology, especially for 
rigid, biopersistent HAR materials and exposure via inhalation [16].  
The group “passive NMs” relates to NMs that are biopersistent, non-fibrous NMs which do not 
have surface reactivity and do not elicit a specific cellular effect and do not prevail in biological fluids 
in a well-dispersed form [2]. Criteria proposed by these authors to assign a NM to this group include 
the absence of toxic component(s) (less than 0.1% by weight), low surface reactivity  
(<10% of Mn2O3 in specific assays), an average agglomeration number ≥3, no cellular effects  
at ≤10 µg/cm 2 and a confirmatory threshold by for example an No Observed Adverse Effect 
Concentration (NOAEC) (>10 mg/m 3) in a short-term inhalation study. The ECETOC concludes that 
passive NMs are considered to possess no or a very low hazard potential, and suggests using a 
threshold value (a No Observed Adverse Effect Concentration NOAEC) of a benchmark passive NM 
for this group, at least for inhalation [2]. In the present paper, it is proposed that issues of special 
attention for the “passive NMs” are at least the distribution to target organs, potential accumulation 
and long-term effects, and for environment biopersistence and trophic transfer. Subsequently, safety 
has to be demonstrated either by testing or read-across as indicated here under “application of read-across”.  
The group “active NMs” relate to NMs with specific toxic constituents and is determined according 
to Arts et al. [2] by chemical composition, dissolution rate, surface reactivity, dispersibility and/or 
cellular effect. ECETOC also proposes that NMs in this group undergo further subgrouping and/or 
require additional testing [2]. Further subgrouping can relate to mechanistic toxicological pathways as 
proposed by Nel et al. [15]: Redox activity and Reactive Oxygen Species (ROS) formation, 
dissolution, shedding toxic ions, cationic toxicity, inflammasome activation, photoactivation, and 
membrane lysis. The authors of the present paper think that special attention for active NMs issues 
should be given to effects related to the mechanistic toxicological pathway as well as distribution to 
target organs, potential accumulation and long-term effects, biopersistency and trophic transfer similar 
to the “passive NMs” group. 
Grouping based on exposure can also steer the risk assessment process. This kind of grouping could 
be based on similar applications and/or processes e.g., the packaging process for a powder, spraying a 
solution, as well as physical form. This kind of information, as for example gathered in the MARINA 
exposure scenario library for NMs [21] is, as indicated before, relevant for RES identification. Also 
information on physicochemical properties during various life cycle stages [25] and information on 
release during specific activities or weathering from similar materials can be informative for RES 
determination. For example, agglomeration may reduce the transportation across biological barriers 
such as gastrointestinal tract [26]. Via this kind of grouping, information on exposure for similar NMs 
can at present be used in the risk assessment process. 
6.3. Ad Five: Scientifically Justified Read-Across for a Specific Endpoint or Test 
When applying read-across (which is always end-point specific and applies to hazard information), 
information on one or more endpoints relevant for risk assessment of a specific NM or of a group of 
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NMs (target material(s)) is predicted by using available data from another NM or group of NMs 
(source material(s)). This means that testing of the target NM or group of target NMs is not required if a 
substantiated justification of why data from the source material(s) are applicable to the target material(s) 
can be provided. For non-nano substances, the ECHA guidance prescribes structural similarity 
between the target and source substance(s) as needed for read-across, for example related to common 
functional groups [10]. The understanding of structural similarity may be relevant for NMs but clearly 
needs further interpretation. Here, we discuss under which circumstances and how information from 
one NM can be used for another NM, both for NMs of the same chemical composition and for NMs of 
different chemical compositions. In addition in some cases, e.g., for quickly dissolving NMs,  
a non-nano (bulk) substance can be used as source material.  
When it is clear at the end of Phase 1 of the MARINA RAS or from regulatory requirements which 
hazard endpoint(s) need(s) to be addressed, read-across among NMs or from bulk materials becomes 
an option. In other words, it can be considered if testing for that specific hazard endpoint is required 
for the NM under investigation, or if it is possible to use data from another material. As for chemicals 
in general, the first step is to identify potential source materials and provide a hypothesis to justify the 
read-across, which are obviously closely connected processes as the use of the source material should 
fit into the justification. Preconditions for read-across are: 
- Information on at least chemical and physical properties and intended use of the target  
material(s) is available.  
- Information on at least chemical and physical properties of the source material is available.  
- Hazard/toxicokinetic data of the source material relevant to the endpoint is available. 
- The quality of the physicochemical and hazard/toxicokinetic data of the source material is high 
and a suitable test procedure is used and described in sufficient detail. 
- The source materials are appropriate for the justification for read-across.  
Justification for read-across will probably be more easy when the physicochemical similarity 
between source and target materials increases. In general, source and target materials will be of the 
same group (quickly dissolving NMs, biopersistent HAR NMs, passive NMs, active NMs) and often of 
the same chemical composition and with a similar production process. Note that, in principle, a 
different justification is possible for different source materials. 
As there is a lack of experience on route-to-route extrapolation for NMs and, in general,  
route-to-route extrapolation also for chemicals is associated with potential difficulties, it is considered 
that for NMs, for the time being, data from a source material can only be used in case of the same 
exposure route for source and target material. For example, NM behaviour can be route-dependent,  
e.g., due to differences in protein binding [27]. In addition, the exposure route is usually related to 
different exposure conditions (exposure medium, duration) and physicochemical properties that can 
affect toxicokinetics and hazard. The MARINA RAS already takes into account that physicochemical 
properties may change during the life cycle, and the information gathering aims at covering the 
physicochemical properties of the NM in the RES [8].  
The data to be used for read-across should be high quality and generated according to a suitable test 
procedure, which is preferably assessed by using a scientifically founded procedure or guidance. The 
OECD-WPMN (Working Party on Manufactured Nanomaterials) concluded that in general the OECD 
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test guidelines are applicable to NMs, and that special attention is needed for the sample preparation 
and dispersion [28–30]. In addition, several EU funded projects are undertaking effort to ensure data 
quality. For example, the NANoREG project (http://nanoreg.eu/) is making major efforts to develop 
guidance and procedures to obtain high quality data for NMs in a harmonised manner to facilitate 
comparisons. These insights can also help to assess the quality of reported data. 
The first possibility to justify read-across is to identify source materials, which have mostly similar 
physicochemical properties and which can be ordered so that the values of the physicochemical 
properties of the target material are encompassed by values of the correspondent physicochemical 
properties of source materials. Hence, target and source materials should be very similar with regard to 
physicochemical properties and the number of available data and the ordering of the variable 
physicochemical property allows for interpolation or use of available data from the worst case source 
material. A substantiated justification should be provided that explains the effect of the variable 
physicochemical property on the endpoint. As several physicochemical properties may vary at the 
same time, it is expected that suitable source materials for NMs rarely exist.  
Another possibility to substantiate justification for read-across is that the identified differences in 
physicochemical properties between source and target material(s) are systematically described and 
assessed, as is also suggested by Walser and Studer [31]. First, the available information on the 
relationships between the physicochemical properties that differ between target and source material(s), 
and exposure, toxicokinetics/fate and hazard relevant for the endpoint under investigation is considered 
and elaborated upon (see Figure 5). This elaboration relates to the properties that describe “Where they go” 
Fundamental behaviour, and “What they do” Reactivity as presented in Figure 1. It may be necessary 
to provide additional information to substantiate these relationships, for example by additional data on 
physicochemical properties of the source and/or target material(s), Quantitative Structure Activity 
Relationships (QSAR) (once available for NMs) [7], general relationships between physicochemical 
properties and exposure, toxicokinetics or hazard, or in vitro or if needed “limited” in vivo testing. 
Finally, for a specific endpoint an overall assessment on the applicability of data from the source 
material(s) to the target material(s) is performed (see Figure 5). For the overall assessment, a 
conservative approach is proposed for the time being by requiring that it can be justified that exposure, 
toxicokinetics/fate and hazard are very similar or worst case for the source material compared to the 
target material. In that case, data from the source material can be used for the endpoint or test under 
consideration for the target material. The concept of applying read-across to a worst case source 
material is similar to the “worst case approach” mentioned in the recently published Read-Across 
Assessment Framework (RAAF) by ECHA [32]. ECHA here indicates that read-across can be applied 
if the strength of the effect(s) of the target substance can be expected to be lower than the strength of 
the effects of the source substance. ECHA suggest that scientific explanations for such situations can 
be based on kinetic considerations and/or potency considerations. 




Figure 5. Considerations for a justification of read-across among NMs for a specific 
relevant exposure route (RES) or endpoint. The differences in chemical and physical 
identity between target and potential source material(s) are considered in relation to their 
relevance for affecting exposure, toxicokinetics/fate and hazard. Hypothesis development 
for read-across justification and identification of potential source materials are related 
processes. The justification can be substantiated by argumentation that exposure to the 
target material is very similar or less than for the source material(s) (exposure element), 
and that a very similar or smaller amount of the target material reaches the target site 
(toxicokinetics/fate element), and the target material is equally or less hazardous than the 
source material (hazard element). This justification needs to be scientifically correct and 
can be based on available knowledge on relationships between physicochemical properties 
and exposure, toxicokinetics/fate and hazard and may be complemented with 
physicochemical data, in silico, in vitro or if needed in vivo data.  
A few examples of how to substantiate the justification are provided here for illustration. 
Argumentation for the exposure element of the justification may for example be based upon the 
expected release or level of exposure, or physicochemical information on the degree of 
aggregation/agglomeration at relevant conditions. For human health, the toxicokinetic element of the 
argumentation may be substantiated by in vitro or (limited) in vivo information on translocation across 
the portal of entry, distribution to and clearance from tissues, or dissolution in macrophage fluid. For 
the environment, the fate element of the argumentation can be substantiated with information on 
release in environmental media (water, sediment, soil, air), or aggregation/agglomeration behaviour or 
complexation behaviour with environmental constituents in these media. The hazard element of the 
argumentation may be substantiated firstly by in silico or in vitro data, and, if needed in vivo data, 
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which may be included to assure the same mode-of-action and to compare the hazard potency between 
source and target material. 
It should be noted that effect(s) of the differences in physicochemical properties between target and 
source material(s) should be considered separately for exposure, toxicokinetics and hazard, due to the 
current limited understanding of the behaviour of NMs, as illustrated by Figure 2  
(on life cycle and biological pathways). Obviously, the proposed worst-case approach on exposure and 
toxicokinetics/fate and hazard may be reconsidered on a case-by-case basis depending on the situation, 
and should be accompanied with a scientifically sound argumentation. Note that the existing 
argumentation on structural similarity, required for read-across of chemical substances  
(e.g., OECD [9], ECHA [10]) is transformed here for NMs into an argument on relationships between 
the variable physicochemical property/ies and exposure, fate/toxicokinetics and hazard. Similar to  
non-nano substances in a regulatory context, toxicokinetic information is considered a key element in 
the argumentation [10]. 
It should also be noted that in the present approach for read-across, it is implicitly assumed that the 
effect under consideration is the same for source and target material. As another type of effect may be 
more critical for the target material, this may require some consideration and discussion in the 
justification. Similarly, differences in uptake mechanism (passive vs. active) between target and source 
material may also need further consideration, for example as non-linear uptake often occurs for active 
mechanisms at increasing concentrations.  
If read-across options seem to be scientifically debatable or time and/or cost intensive, actual testing 
of the target material may be a better option.  
7. Final Considerations and Future Developments 
The presented approaches for grouping and read-across pave the way for making best use of 
available knowledge on tested nano and non-nano materials to obtain information needed for risk 
assessment of one or more (toxicologically) untested or unassessed NMs. To this end, grouping of 
NMs can be used for different reasons, and these are: (i) to acquire information on one or more RESs 
or endpoints via a targeted testing strategy whose results cover the entire group of NMs, (ii) to identify 
generic groups based on information on similar materials to guide the identification of further 
information needs and indicate possibilities for read-across early in the risk assessment process,  
(iii) to come to a scientifically founded argumentation for read-across to a target NMs for a specific 
endpoint by using data from source material(s). The generic grouping approaches allow for further 
subgrouping based upon increased knowledge on the relationships between physicochemical properties 
and exposure, fate/toxicokinetics and (eco)toxicity. A nanomaterial may belong to more than one 
group, e.g., if a NM is quickly dissolving and with an HAR, or related to the different applications of 
groupings and read-across. For example, an NM can be allocated to a group based on similar 
physicochemical properties to design a testing strategy whose results cover the entire group  
(ad 1 in Figure 4). Subsequently, in Phase 1 of the RAS information, similar materials are used to 
highlight information needs on hazard and exposure in the data gathering process  
(ads 3 and 4 in Figure 4, respectively), and, finally, for specific endpoints in Phase 2 of the RAS,  
read-across to data of specific source materials is considered (ad 5 in Figure 4). 
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It should be noted that the presented overview of approaches for grouping and possibilities for 
application in the MARINA RAS are discussed at a rather abstract level. In order to increase the 
robustness, practical application, i.e., via case studies is essential. Another important issue that still 
needs to be addressed is how to deal with uncertainty in the risk assessment, grouping and read-across 
process. More and more developments are ongoing to include information on uncertainty as for 
example in an approach laid down by Gajewicz et al. [33] for preliminary hazard assessment and 
hazard prediction. Furthermore, details on decision making should be developed. These issues will be 
taken up in the future. 
The overview clearly shows that information on a number of physicochemical properties of an NM 
should be available to start the information gathering process and to consider options for grouping and 
read-across. Without this information, these processes cannot be initiated. 
Furthermore, it is acknowledged that building and substantiating a scientifically founded  
read-across argumentation is in most cases a work-intensive process, though it is expected to become 
easier and be more successful as more high quality data of NMs, i.e., more potential source materials, 
become publicly available and as knowledge on relationships between NM properties and exposure, 
toxicokinetics and hazard increases. Better understanding on the behaviour of NMs further enables the 
development of more in silico tools and simple tests that can be used to substantiate the exposure, 
toxicokinetic or hazard element of the justification. For example, in vitro tests for a specific 
mechanistic injury pathway as suggested by Nel et al. [15] can be developed to obtain information for 
the hazard element of the read-across argumentation for human health. A simple test like dissolution in 
macrophage fluid may be used to substantiate that a source material accumulates to a smaller extent in 
a target site within a living organism than a target material. Development and steps towards acceptance 
of such simple tests including description of their applicability is highly recommended. 
In conclusion, grouping and read-across can be valuable tools to limit the amount of testing for risk 
assessment of nanomaterials and at the same time meet the prerequisite to obtain sufficient information 
to assess the safety. Different applications for grouping and read-across of nanomaterials can be 
distinguished and have been presented within the broader perspective of the MARINA Risk 
Assessment Strategy. These approaches pave the way for better use of available information on 
nanomaterials and are flexible enough to allow future adaptations related to scientific developments. 
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